A landmark book by the senior science writer at Time magazine introduces us to a medical breakthrough that can save our lives. Few people know much about stem cell research beyond the ethical questions raised by using embryos. But in the last decade, stem cell research has made huge advances toward eliminating some of our most intractable […]
Introduction Infectious complications constitute an important cause of morbidity and mortality in patients who undergo hematopoietic progenitor transplantation (HSCT). Bloodstream infections are among the most frequent bacterial infections in these patients, and central vascular catheters are a very common source of the bacteremia [1,2]. Catheter-related bacteremia (CRB) is an increasing-in-frequency and potentially life-threatening complication.
Introduction Since its identification in 1981, human immunodeficiency virus (HIV) infection and the associated acquired immunodeficiency syndrome (AIDS) remain a major health burden globally. Recent estimates indicate that over 35 million people are affected worldwide, with mortality counts of over 20 million . About 70% of these deaths have occurred in sub-Saharan Africa , where […]
To begin, it should be clarified that the term “artificial blood” is really a misnomer. The complexity of blood is far too great to allow for absolute duplication in a laboratory. Instead, researchers have focused their efforts on creating artificial substitutes for 2 important functions of blood: oxygen transport by red blood cells and hemostasis […]
Byline: Mohammad Hossein Baradaranfar, Shokouh Taghipour Zahir, Saeid Atighechi, Mohammad Hossien Dadgarnia, Fahimeh Bayati and Mohammad Reza Mohajerani ABSTRACT
Every innovation in medicine is met with a mixture of excitement, expectation and a certain degree of apprehension. Nowhere is this more apparent than in the field of cell-based therapy, i.e. the application of cells to patients, locally or systemically, for therapeutic purposes. Excitement and expectation are generated by the many preclinical and early clinical […]
It is widely understood that stem cell treatments have the potential to revolutionize medicine. Because of this potential, in 2004 California voters approved Proposition 71 to set up a 10-year, $3 billion program to fund research on stem cells. Under the direction of the California Institute for Regenerative Medicine, this program will pay to build […]